Inspire Medical Systems Announces Participation at SLEEP 2026 and PREDICTOR Study Publication

Inspire Medical Systems, Inc. is set to showcase its innovative Inspire platform at SLEEP 2026, with emphasis on new clinical insights regarding hypoxic burden and cardiovascular outcomes. The company also announced the publication of the PREDICTOR study, which identifies body mass index and neck circumference as key predictors for screening patients for Inspire therapy eligibility, potentially streamlining the diagnostic process and reducing healthcare costs.